Hewlett Packard Enterprise (HPE) has agreed to purchase Juniper Networks (JNPR) for $14 billion or $40/share in an all-cash deal. The deal is expected to close in late 2024 or early 2025. Since there are many players in this space, this deal is not expected to get a lot of anti-trust scrutiny. (CNBC)
Chesapeake Energy (CHK) has agreed to acquire Southwestern Energy (SWN) in an all-stock deal worth $7.4 billion. This move positions Chesapeake Energy as the leading independent U.S. natural gas producer. This merger is a strategic move based on confidence in the ongoing success of LNG exports. The stock transaction values Southwestern Energy shares at $6.69. The deal is expected to close in the second quarter of 2024. (Marketwatch)
J&J (JNJ) announced its acquisition of Ambrx Biopharma (AMAM) for $2 billion, aiming to acquire potential targeted cancer therapies referred to as antibody drug conjugates (ADC). The transaction involves purchasing Ambrx at $28.00 per share in cash. Anticipated to be finalized in the first half of 2024, this deal reflects J&J’s strategic move to strengthen its position in the field of innovative cancer treatments. (Businesswire)
On Monday, Merck & Co (MRK) announced its acquisition of Harpoon Therapeutics (HARP) for approximately $680 million or $23 in cash. This move aims to strengthen Merck’s oncology portfolio by incorporating Harpoon Therapeutics’ expertise in cancer drug development, particularly in the field of immunotherapies. The acquisition is expected to be completed in the first half of 2024. (Yahoo Finance)